α1抗胰蛋白酶MZ杂合子为慢阻肺内型
该研究基于三项独立全基因组测序数据,比较MZ与MM基因型慢阻肺患者的临床特征。纳入290例MZ和6184例MM慢阻肺患者,发现MZ者FEV1%预计值更低、CT肺气肿更重,提示MZ为慢阻肺内型。
要点
- MZ杂合子慢阻肺患者较MM者FEV1低3.9%、肺气肿多4.14%。
- MZ与MM间肺组织PGF基因表达存在差异。
- MZ杂合子可能代表慢阻肺的一种内型。
核心结论
- 携带AAT Z等位基因的MZ杂合子慢阻肺患者肺功能更低、肺气肿更重,提示MZ为慢阻肺内型。
研究设计与样本
- 研究利用三项独立研究的全基因组测序数据确定SERPINA1基因型,比较MZ与MM慢阻肺患者结局并做荟萃分析。
- 共纳入290例MZ慢阻肺患者和6184例MM慢阻肺患者。
主要发现
- MZ慢阻肺患者FEV1%预计值低于MM者,CT定量肺气肿更重。
- 荟萃分析显示MZ者FEV1低3.9%(95%CI -6.55%至-1.26%),肺气肿(<-950 HU区域百分比)多4.14%(95%CI 1.44%至6.84%)。
- 一项研究肺组织中PGF基因在MZ与MM间存在差异表达。
临床怎么用
- 对慢阻肺患者可考虑SERPINA1基因型检测以识别MZ内型。
- MZ慢阻肺患者可能需更关注肺功能下降和肺气肿进展。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Multiple studies have demonstrated an increased risk of chronic obstructive pulmonary disease (COPD) in heterozygous carriers of the AAT (alpha-1 antitrypsin) Z allele. However, it is not known if MZ subjects with COPD are phenotypically different from noncarriers (MM genotype) with COPD. Objectives: To assess if MZ subjects with COPD have different clinical features compared with MM subjects with COPD. Methods: Genotypes of SERPINA1 were ascertained by using whole-genome sequencing data in three independent studies. We compared outcomes between MM subjects with COPD and MZ subjects with COPD in each study and combined the results in a meta-analysis. We performed longitudinal and survival analyses to compare outcomes in MM and MZ subjects with COPD over time. Measurements and Main Results: We included 290 MZ subjects with COPD and 6,184 MM subjects with COPD across the three studies. MZ subjects had a lower FEV1% predicted and greater quantitative emphysema on chest computed tomography scans compared with MM subjects. In a meta-analysis, the FEV1 was 3.9% lower (95% confidence interval [CI], -6.55% to -1.26%) and emphysema (the percentage of lung attenuation areas <-950 HU) was 4.14% greater (95% CI, 1.44% to 6.84%) in MZ subjects. We found one gene, PGF (placental growth factor), to be differentially expressed in lung tissue from one study between MZ subjects and MM subjects. Conclusions: Carriers of the AAT Z allele (those who were MZ heterozygous) with COPD had lower lung function and more emphysema than MM subjects with COPD. Taken with the subtle differences in gene expression between the two groups, our findings suggest that MZ subjects represent an endotype of COPD.
引用
- Ghosh AJ, Hobbs BD, Moll M, et al. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022. PMID: 34762809. doi:10.1164/rccm.202106-1404OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。